CoE CIT in the News

World leading cellular immunotherapy research in the news

CoE CIT announces collaboration with Cartherics for the treatment of cutaneous T-cell lymphoma (CTCL)

CoE CIT  announces it is joining forces with America’s Penn Medicine (University of Pennsylvania Health System)

First commercial CAR-T therapy to be manufactured in Australia at Peter MacCallum Cancer Centre 

Milestone as Australia's first T-cell therapy manufacturing license is awarded to Peter Mac based company 

The CoE CIT successfully gains funding and is announced